In an expanded partnership agreement, artificial intelligence (AI) breast imaging software developer Densitas will integrate additional software applications into the Blackford Platform.
One Densitas product, densitas riskAI, is a point-of-care rapid risk assessment tool designed to support tailored follow-up breast screening protocols and help clinicians identify the right patients to refer to supplemental mammography screening.
A second application to be integrated on the Blackford Platform is Densitas' densityAI program, which provides standardized breast density assessments in alignment with the American College of Radiology's BI-RADS fifth edition guidance.
As part of the Blackford Platform, Densitas' products will be more accessible to the broader U.S. market, and customer integrations can be simplified, company representatives said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
